Literature DB >> 21460394

Walking the walk from genes through telomere maintenance to cancer risk.

Elizabeth H Blackburn1.   

Abstract

Recent studies have shown associations between human population single-nucleotide polymorphisms (SNP) and white blood cell telomere shortness; independently, telomere shortness has been associated with higher risks of various cancers. However, no single previous study simultaneously linked a given SNP both with telomere length and reduced risk of cancer. In this issue of the journal (beginning on page 514), Gu and colleagues report four new SNPs associated, in three cohorts, with telomere length. One of these SNPs predicted risk for bladder cancer, an effect partially mediated by telomere length. Interventions that could forestall telomere shortening should be explored for their potential to reduce cancer risks. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21460394     DOI: 10.1158/1940-6207.CAPR-11-0066

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  14 in total

1.  Telomere length and telomerase activity; a Yin and Yang of cell senescence.

Authors:  Mary Derasmo Axelrad; Temuri Budagov; Gil Atzmon
Journal:  J Vis Exp       Date:  2013-05-22       Impact factor: 1.355

2.  Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells.

Authors:  John Ramunas; Eduard Yakubov; Jennifer J Brady; Stéphane Y Corbel; Colin Holbrook; Moritz Brandt; Jonathan Stein; Juan G Santiago; John P Cooke; Helen M Blau
Journal:  FASEB J       Date:  2015-01-22       Impact factor: 5.191

3.  The BATTLE to personalize lung cancer prevention through reverse migration.

Authors:  Kathryn A Gold; Edward S Kim; J Jack Lee; Ignacio I Wistuba; Carol J Farhangfar; Waun Ki Hong
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

4.  Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention.

Authors:  Kelly A Biegler; Amanda K L Anderson; Lari B Wenzel; Kathryn Osann; Edward L Nelson
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-24

5.  Interplay between Top1 and Mms21/Nse2 mediated sumoylation in stable maintenance of long chromosomes.

Authors:  Lakshmi Mahendrawada; Ragini Rai; Deepash Kothiwal; Shikha Laloraya
Journal:  Curr Genet       Date:  2016-11-21       Impact factor: 3.886

Review 6.  Telomere maintenance and the etiology of adult glioma.

Authors:  Kyle M Walsh; John K Wiencke; Daniel H Lachance; Joseph L Wiemels; Annette M Molinaro; Jeanette E Eckel-Passow; Robert B Jenkins; Margaret R Wrensch
Journal:  Neuro Oncol       Date:  2015-05-25       Impact factor: 12.300

7.  A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine.

Authors:  Angela R Starkweather; Debra E Lyon; R K Elswick; Alison J Montpetit; Yvette Conley; Nancy L McCain
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-09

8.  A biobehavioral perspective on telomere length and the exposome.

Authors:  Debra E Lyon; Angela R Starkweather; Alison Montpetit; Victoria Menzies; Nancy Jallo
Journal:  Biol Res Nurs       Date:  2014-03-04       Impact factor: 2.522

9.  Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia.

Authors:  Juhi Ojha; Veryan Codd; Christopher P Nelson; Nilesh J Samani; Ivan V Smirnov; Nils R Madsen; Helen M Hansen; Adam J de Smith; Paige M Bracci; John K Wiencke; Margaret R Wrensch; Joseph L Wiemels; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-13       Impact factor: 4.254

10.  Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.

Authors:  Kyle M Walsh; Todd P Whitehead; Adam J de Smith; Ivan V Smirnov; Minsun Park; Alyson A Endicott; Stephen S Francis; Veryan Codd; Nilesh J Samani; Catherine Metayer; Joseph L Wiemels
Journal:  Carcinogenesis       Date:  2016-04-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.